beQpress
Pressmeddelanden
Datum
Ämne
Språk
2021-12-10
Urb-it: Report from extraordinary general meeting in Urb-it on 10 December 2021
English
2020-12-01
Cibus: Cibus explores the conditions for carrying out a directed share issue
English
2021-02-16
Arcane Crypto: Arcane Crypto has entered into a term sheet with Lucerne Capital Management and Klein Invest AS regarding an investment of approximately USD 6 million in Arcane Crypto
English
2021-03-05
Meltron: Meltron - changes in sales organisation
English
2023-11-28
Lipigon: Lipigon presents Lipisense® at Global CVCT Forum 2023
English
2020-11-05
Unibap: Unibap successfully demonstrates the L3Harris Geospatial ENVI/IDL professional software on SpaceCloud in collaboration with SaraniaSat
English
2023-05-23
Annehem Fastigheter: Bulletin from Annehem's Annual General Meeting on 23 May 2023
English
2024-01-12
JonDeTech: Today the exercise period for warrants of series TO2 begins
English
2021-04-09
Adventure Box: GESTRUMENT LETS ADVENTURE BOX USERS CREATE ADAPTIVE MUSIC
English
2021-04-13
Bluelake Mineral: Announcement of Extraordinary General Meeting in Bluelake Mineral AB (publ)
English
2020-06-29
Zhoda Investments: Zhoda Investments announces an operational update
English
2023-04-17
Arcario: Arcario Unveils Global Launch of K33 Platform Following Successful Beta Testing
English
2023-09-04
Annehem Fastigheter: Annehem Fastigheter AB appoints new CFO
English
2021-11-19
Emplicure: Emplicure interim report January-September 2021 - Building a strong team and a foundation for growth
English
2023-11-29
PILA PHARMA: THE ONGOING RIGHTS ISSUE IN PILA PHARMA HAS ENTERED ITS LAST SUBSCRIPTION WEEK AND WILL END MONDAY 4 DECEMBER. THE LAST DAY OF TRADING SUBSCRIPTION RIGHTS IS WEDNESDAY 29 NOVEMBER
English
2023-03-30
Unibap: Unibap receives a follow-on order from the Japan Aerospace Exploration Agency (JAXA)
English
2022-08-04
Flerie Invest: Flerie Invest AB has increased its holding in Xintela AB, whereby the lim-it for mandatory bidding has been exceeded
English
2022-04-27
Gesynta: Gesynta Pharma's drug candidate GS-248 granted Orphan Drug Designation in US by the FDA for the treatment of systemic sclerosis
English
2022-02-04
PILA PHARMA: PILA PHARMA AB, announces API manufacturing milestone achieved and changes to organisation
English
2022-02-25
Arcane Crypto: Arcane Crypto publishes Interim Report for Q4 and full year 2021
English
Föregående
[ 50 ]
Nästa